Spruce Biosciences, Inc
NASDAQ:SPRB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spruce Biosciences, Inc
NASDAQ:SPRB
|
US |
|
Neometals Ltd
ASX:NMT
|
AU |
|
E
|
Eson Precision Ind Co Ltd
TWSE:5243
|
KY |
|
Schindler Holding AG
F:SHR0
|
CH |
|
Viohalco SA
F:VHC
|
BE |
|
D
|
Dell Technologies Inc
F:12DA
|
US |
|
S
|
Scor SE
XMUN:SDRC
|
FR |
|
V
|
Vodafone Group PLC
F:VODI
|
UK |
|
R
|
Reach PLC
SWB:MRR
|
UK |
|
C
|
Compagnie de Saint Gobain SA
F:GOB
|
FR |
|
D
|
DTE Energy Co
F:DGY
|
US |
|
P
|
Patel Integrated Logistics Ltd
BSE:526381
|
IN |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
V
|
Vallourec SA
F:VACD
|
FR |
|
S
|
SBM Offshore NV
XMUN:IHCB
|
NL |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
|
Bang Overseas Ltd
NSE:BANG
|
IN |
|
A
|
Autotrader Group PLC
OTC:ATDRF
|
UK |
|
B
|
BioMarin Pharmaceutical Inc
XMUN:BM8
|
US |
Bankruptcy Probability
Spruce Biosciences, Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Spruce Biosciences, Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Spruce Biosciences, Inc
NASDAQ:SPRB
|
149.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
463.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
58.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
49.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Spruce Biosciences, Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Spruce Biosciences, Inc has total debt of 5.5m USD. This includes both short-term (0 USD) and long-term (5.5m USD) debt.
You can find a full breakdown on its Balance Sheet.